We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+19.18%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$14.1B
AUM Growth
+$3.8B
Cap. Flow
+$2.09B
Cap. Flow %
14.81%
Top 10 Hldgs %
19.63%
Holding
2,124
New
675
Increased
443
Reduced
410
Closed
576

Top Sells

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$131M
2
MSFT icon
Microsoft
MSFT
+$129M
3
V icon
Visa
V
+$119M
4
BKNG icon
Booking.com
BKNG
+$86M
5
HUM icon
Humana
HUM
+$82.2M

Sector Composition

Rank Sector Weight
1 Healthcare 31.67%
2 Technology 15.37%
3 Consumer Discretionary 10.44%
4 Industrials 8.59%
5 Financials 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EIGI
2051
DELISTED
Endurance International Group Holdings, Inc.
EIGI
-10,084
Closed -$67K
DNKN
2052
DELISTED
Dunkin' Brands Group, Inc.
DNKN
-2,281
Closed -$146K
WMGI
2053
DELISTED
Wright Medical Group Inc
WMGI
-23,709
Closed -$645K
IMMU
2054
DELISTED
Immunomedics Inc
IMMU
-18,555
Closed -$265K
CCMP
2055
DELISTED
CMC Materials, Inc. Common Stock
CCMP
-6,608
Closed -$630K
DZSI
2056
DELISTED
DZS Inc. Common Stock
DZSI
-1,300
Closed -$18K
FSCT
2057
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
-159,480
Closed -$4.15M
TLRD
2058
DELISTED
Tailored Brands, Inc.
TLRD
-2,411
Closed -$33K
PTLA
2059
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
-4,096
Closed -$80K
TECD
2060
DELISTED
Tech Data Corp
TECD
-13,197
Closed -$1.08M
STML
2061
DELISTED
Stemline Therapeutics, Inc.
STML
-3,324
Closed -$32K
LTM
2062
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
-19,777
Closed -$204K
TIVO
2063
DELISTED
Tivo Inc
TIVO
-3,391
Closed -$32K
WBC
2064
DELISTED
WABCO HOLDINGS INC.
WBC
-440
Closed -$47K
CARO
2065
DELISTED
Carolina Financial Corp.
CARO
-699
Closed -$21K
WAAS
2066
DELISTED
AquaVenture Holdings Limited
WAAS
-2,472
Closed -$47K
INAP
2067
DELISTED
Internap Corporation
INAP
-18,320
Closed -$76K
FOMX
2068
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
-23,230
Closed -$83K
DPLO
2069
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
-2,389
Closed -$32K
CISN
2070
DELISTED
Cision Ltd. Ordinary Share
CISN
-299,224
Closed -$3.5M
JAG
2071
DELISTED
Jagged Peak Energy Inc.
JAG
-8,777
Closed -$80K
ASNA
2072
DELISTED
Ascena Retail Group, Inc.
ASNA
-4,165
Closed -$209K
STNL
2073
DELISTED
Sentinel Energy Services Inc. Class A Common Stock
STNL
$0 ﹤0.01%
+15
New +$151
MDSO
2074
DELISTED
Medidata Solutions, Inc.
MDSO
-6,752
Closed -$455K
ISCA
2075
DELISTED
International Speedway Corp
ISCA
-21,518
Closed -$944K

Similar funds

Marshall Wace North America's Q1 2019 Portfolio in Review

As of Q1 2019, Marshall Wace North America held 2,124 positions worth $14.1B, up 37% from $10.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace North America deployed $2.09B of net new capital in Q1 2019, opening 675 new positions and adding to 443 existing holdings. Its largest new stake was bluebird bio: 36,744 shares worth $74.9M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Comcast, an estimated $131M trimmed.

  • Marshall Wace North America's largest Q1 2019 buy was bluebird bio: 36,744 shares worth $74.9M.
  • Marshall Wace North America added most to Fidelity National Information Services in Q1 2019, an estimated $188M increase.
  • Marshall Wace North America's biggest Q1 2019 reduction was Comcast, cutting an estimated $131M.
  • Marshall Wace North America fully exited Cboe Global Markets in Q1 2019, selling an estimated $67.7M.
  • Marshall Wace North America's ten largest holdings make up 20% of its $14.1B portfolio in Q1 2019.
  • Marshall Wace North America opened 675 new positions and closed 576 in Q1 2019.
  • Marshall Wace North America's portfolio value rose 37% quarter-over-quarter to $14.1B.

Based on Marshall Wace North America's 13F filing for Q1 2019, filed 14 May 2019.